4//SEC Filing
Zuga Matt 4
Accession 0001628280-26-001265
CIK 0001576885other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 9:31 PM ET
Size
11.5 KB
Accession
0001628280-26-001265
Insider Transaction Report
Form 4
Zuga Matt
CFO & Chief Business Officer
Transactions
- Sale
Common Stock
2026-01-05$1.96/sh−4,000$7,842→ 227,744 total - Sale
Common Stock
2026-01-06$1.97/sh−5,100$10,028→ 222,644 total - Sale
Common Stock
2026-01-07$2.00/sh−4,105$8,189→ 218,539 total - Sale
Common Stock
2026-01-07$1.99/sh−1,700$3,377→ 216,839 total
Footnotes (6)
- [F1]Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024.
- [F2]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9100 to $1.9750. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9400 to $1.9900. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9500 to $2.0400. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of RSUs pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 30, 2025.
- [F6]The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9600 to $2.0100. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Acumen Pharmaceuticals, Inc.
CIK 0001576885
Entity typeother
Related Parties
1- filerCIK 0001790214
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 9:31 PM ET
- Size
- 11.5 KB